Enhancing Antimicrobial Peptides from Frog Skin: A Rational Approach

Area of Science:

• Biochemistry
• Drug Discovery
• Computational Biology

Background:

• Antimicrobial resistance (AMR) is a critical global health challenge.
• New antibiotic development is slow, necessitating alternative strategies.
• Antimicrobial peptides (AMPs) offer a promising avenue for novel therapeutics.

Purpose of the Study:

• To rationally design and optimize antimicrobial peptides (AMPs) derived from hylin-Pul3.
• To enhance AMP efficacy, selectivity, and accelerate drug discovery.
• To investigate structure-activity relationships for improved therapeutic potential.

Main Methods:

• Rational design by optimizing hydrophobicity, cationicity, and amphipathicity of hylin-Pul3.
• In silico screening to identify promising peptide candidates.
• In vitro assays including antibacterial, hemolytic, fibroblast, antioxidant, and lipid membrane interaction studies.
• Machine learning models for bioactivity prediction.

Main Results:

• Six novel peptide derivatives (dHP3-31, dHP3-50, dHP3-50.137, dHP3-50.190, dHP3-84, dHP3-84.39) were identified with enhanced Gram-negative activity.
• Derivatives showed improved selectivity, with some promoting cell proliferation and others exhibiting antioxidant properties.
• Lipid membrane interaction studies suggested varied mechanisms, including direct disruption, vesicle aggregation, and potential intracellular action for dHP3-84.
• Machine learning accurately predicted enhanced bioactivity, selectivity, and potency.

Conclusions:

• Rational design and in silico screening are effective for optimizing AMPs.
• Optimized AMPs, particularly dHP3-84, show broad-spectrum potential and therapeutic promise.
• Structure-activity relationship studies are crucial for developing next-generation antimicrobial agents.